» Articles » PMID: 32610439

Poly-arginine-18 (R18) Confers Neuroprotection Through Glutamate Receptor Modulation, Intracellular Calcium Reduction, and Preservation of Mitochondrial Function

Overview
Journal Molecules
Publisher MDPI
Specialty Biology
Date 2020 Jul 3
PMID 32610439
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies have highlighted that a novel class of neuroprotective peptide, known as cationic arginine-rich peptides (CARPs), have intrinsic neuroprotective properties and are particularly effective anti-excitotoxic agents. As such, the present study investigated the mechanisms underlying the anti-excitotoxic properties of CARPs, using poly-arginine-18 (R18; 18-mer of arginine) as a representative peptide. Cortical neuronal cultures subjected to glutamic acid excitotoxicity were used to assess the effects of R18 on ionotropic glutamate receptor (iGluR)-mediated intracellular calcium influx, and its ability to reduce neuronal injury from raised intracellular calcium levels after inhibition of endoplasmic reticulum calcium uptake by thapsigargin. The results indicate that R18 significantly reduces calcium influx by suppressing iGluR overactivation, and results in preservation of mitochondrial membrane potential (ΔΨm) and ATP production, and reduced ROS generation. R18 also protected cortical neurons against thapsigargin-induced neurotoxicity, which indicates that the peptide helps maintain neuronal survival when intracellular calcium levels are elevated. Taken together, these findings provide important insight into the mechanisms of action of R18, supporting its potential application as a neuroprotective therapeutic for acute and chronic neurological disorders.

Citing Articles

Novel Poly-Arginine Peptide R18D Reduces α-Synuclein Aggregation and Uptake of α-Synuclein Seeds in Cortical Neurons.

Robinson E, Gorecki A, Pesce S, Bagda V, Anderton R, Meloni B Biomedicines. 2025; 13(1).

PMID: 39857706 PMC: 11763338. DOI: 10.3390/biomedicines13010122.


The Effects of Enriched Rehabilitation on Cognitive Function and Serum Glutamate Levels Post-stroke.

Wang X, Peng Y, Zhou H, Du W, Wang J, Wang J Front Neurol. 2022; 13:829090.

PMID: 35370905 PMC: 8967952. DOI: 10.3389/fneur.2022.829090.

References
1.
Duncan R, Goad D, Grillo M, Kaja S, Payne A, Koulen P . Control of intracellular calcium signaling as a neuroprotective strategy. Molecules. 2010; 15(3):1168-95. PMC: 2847496. DOI: 10.3390/molecules15031168. View

2.
Milani D, Bakeberg M, Cross J, Clark V, Anderton R, Blacker D . Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies. PLoS One. 2018; 13(3):e0193884. PMC: 5841795. DOI: 10.1371/journal.pone.0193884. View

3.
Planells-Cases R, Aracil A, Merino J, Gallar J, Perez-Paya E, Belmonte C . Arginine-rich peptides are blockers of VR-1 channels with analgesic activity. FEBS Lett. 2000; 481(2):131-6. DOI: 10.1016/s0014-5793(00)01982-7. View

4.
Nicholls D . Mitochondrial dysfunction and glutamate excitotoxicity studied in primary neuronal cultures. Curr Mol Med. 2004; 4(2):149-77. DOI: 10.2174/1566524043479239. View

5.
Lau A, Tymianski M . Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010; 460(2):525-42. DOI: 10.1007/s00424-010-0809-1. View